News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|December 27, 2022

Scynexis CEO talks recent ibrexafungerp approval

Author(s)Morgan Ebert, Managing Editor

Marco Taglietti, MD, president and CEO of Scynexis, sits with Contemporary OB/GYN® to discuss the recent approval of ibrexafungerp (Brexafemme) for the reduction in incidence of recurrent vulvovaginal candidiasis.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

FDA approves Aptima HPV assay for clinician-collected primary cervical cancer screening

FDA approves Aptima HPV assay for clinician-collected primary cervical cancer screening

ByBenjamin P. Saylor

February 4th 2026

Recapping January's top Contemporary OB/GYN headlines | Image Credit: © sebra- stock.adobe.com.

Recapping January's top Contemporary OB/GYN headlines

ByJoshua Fitch, Senior Editor

February 3rd 2026

Aviva to advance, announce new data for AVA-291 women's testosterone therapy | Image credit: Contemporary OB/GYN

Aviva to advance, announce new data for AVA-291 women's testosterone therapy

ByJoshua Fitch, Senior Editor

January 26th 2026

RE104 30 mg demonstrates efficacy and safety in new phase 2 data for postpartum depression | Image Credit: © oksix - © oksix- stock.adobe.com.

RE104 30 mg demonstrates efficacy and safety in new phase 2 data for postpartum depression

ByJoshua Fitch, Senior Editor

January 20th 2026

FDA extends etonogestrel implant 68 mg indication up to 5 years | Image credit: Contemproary OB/GYN

FDA approves 5-year use for etonogestrel implant 68 mg contraceptive

ByJoshua Fitch, Senior Editor

January 19th 2026

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

Minipad-based HPV testing shows promise for cervical cancer screening

Study data highlight trade-offs of testing for pregnancy too soon

Kevin Ault, MD, on vaccines & autism, local government, HPV vaccine advocacy

Fionnuala McAuliffe, MD, highlights importance of timely breastfeeding discussions with patients

Barbara Levy, MD, on importance of public comments on new cervical cancer screening guidance